Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...
A handful of antibody-based extracellular targeted protein degraders are advancing in the clinic, highlighting emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results